Key facts
- Notable investors include LRVHealth.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for LucyRx
- ·The full record, as it builds
Funding rounds
No funding rounds for LucyRx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LucyRx
Provider of pharmacy benefit management services intended to clarify prescription drug cost management. The company offers a wide range of services, including personalized prescription management, pricing transparency, optimized health plans, round-the-clock assistance, medication information and advice, health and wellness tips, and more, enabling health plans, employers, and patients to manage prescription benefits with clearer cost information, tailored clinical support, and improved operational efficiency across national healthcare programs.
- Sector
- Healthcare
- HQ
- Bethesda, MD, United States
- Founded
- 2023
- Employees
- 184
- Website
- lucyrx.com/
- Ownership
- Privately Held (backing)
LucyRx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LucyRx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LucyRx in its N-PORT filings yet. We sweep new filings monthly.